Aralez finally gets an FDA OK for its cardio drug Yosprala, starts hiring sales reps
The third time proved the charm for Aralez Pharmaceuticals. After two years of back and forth with the FDA over a serious manufacturing snafu, the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
